Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab

Explore clinical trials studying Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab trial results

Recruiting

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

NCT05901285

Conditions
Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • George Washington University Washington D.C., District of Columbia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions